Zacks Company Profile for 9 Meters Biopharma, Inc. (NMTR : NSDQ) |
|
|
|
Company Description |
9 Meters Biopharma, Inc. is a rare, orphan and unmet needs focused GI company. It's advancing NM-002, a proprietary long-acting GLP-1 agonist into Phase 2 trial for Short Bowel Syndrome, a rare, orphan disease, as well as larazotide, a Phase 3 tight junction regulator being evaluated for patient-reported symptom. 9 Meters Biopharma Inc., formerly known as Innovate Bioph, is based in Raleigh, United States.
Number of Employees: 21 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $0.47 |
Daily Weekly Monthly
 |
20 Day Moving Average: 1,344,328 shares |
Shares Outstanding: 259.11 (millions) |
Market Capitalization: $121.78 (millions) |
Beta: 0.30 |
52 Week High: $1.55 |
52 Week Low: $0.35 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
3.16% |
16.18% |
12 Week |
-15.04% |
-6.60% |
Year To Date |
-51.98% |
-46.34% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
John Temperato - Chief Executive Officer and President
Bethany Sensenig - Chief Financial Officer
Lorin K. Johnson - Director
Michael T. Constantino - Director
Michael Rice - Director
|
|
Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 654405109
SIC: 2834
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/11/22
|
|
Share - Related Items
Shares Outstanding: 259.11
Most Recent Split Date: 2.00 (0.10:1)
Beta: 0.30
Market Capitalization: $121.78 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $-0.04 |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $-0.17 |
Payout Ratio: |
Number of Estimates in the Fiscal Year Consensus: 4.00 |
Change In Payout Ratio: |
Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 08/11/22 |
|
|
|
|